Immuneering Corp. (IMRX)
5.12
+0.10
(+1.99%)
USD |
NASDAQ |
Mar 23, 16:00
5.09
-0.03
(-0.59%)
Pre-Market: 09:20
Immuneering Total Assets (Quarterly) : 231.98M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 488.95M |
| Verastem, Inc. | 246.44M |
| Phathom Pharmaceuticals, Inc. | 259.80M |
| Tango Therapeutics, Inc. | 410.01M |
| X4 Pharmaceuticals, Inc. | 290.46M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 13.50M |
| Shareholders Equity (Quarterly) | 218.48M |
| Debt to Equity Ratio | 0.0175 |
| Current Ratio | 17.50 |
| Net Debt Paydown Yield | 0.02% |